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Welcome to this special issue on ‘biological 
radioprotection’ of Defence Life Science Journal (DLSJ). 
The journal is published by Defence Scientific Information 
& Documentation Centre (DESIDOC) on behalf of Defence 
Research and Development Organisation (DRDO), Govt. 
of India. Biological radioprotection is an uncherris goal 
for radiation biologist at global scale. Despite six decade’s 
continuous efforts, global scientific community is still searching 
for a radiation countermeasure agent which can be used during 
radiation emergency scenario. Though, few radioprotective 
agents received IND status by US-FDA however, so far not 
a single drug is approved for human uses globally. The major 
obstacles to achieve biological radioprotection are i.e. variable 
severity of biological damage with different types of radiation 
and dose rate, differential RBE for low LET and high LET 
radiation, variable radiosensitivity of biological systems, 
unpractical time and drug therapeutic dose window and 
unacceptable toxicity at efficacious dose of a radioprotective 
agent, etc. Despite serious efforts, till date no drug molecule 
was qualified at all ideal parameters to achieve biological 
radioprotection. India is a declared nuclear state, and military 
grade radioactive fuel enrichment process is always prone to 
accidents. India enhancing its capabilities in the area of nuclear 
energy increases the probability of accidental radiation release 
as evident in the past in USSR (Chernobyl, 1986) and Japan 
(Fukushima, 2011). Apart from that, being huge medical 
diagnostic and therapeutic pressure, installations of gamma 
irradiators, X-ray machines, CT scanners and PET scanners are 
increasing in hospitals, further complicating the situation and 
alarming us for possible radiation incident/accident in future 
anywhere in the world. Past history is full of nuclear incidents/
accidents in military as well as civilian establishments and 
nobody can ensure desired level of safety and protection 
against future nuclear accidents. Nuclear terrorism is another 
dimension of immediate attention. Radiological dispersal 
device (RDD) detonation, dirty bomb explosion by non state 
actors or even nuclear attack by enemy states cannot be ruled 
out completely. In view of above, development of effective, 
nontoxic and approved radiation countermeasure is the need 
of hours but unfortunately it is not available anywhere in the 
world. 
During mass casualty scenario, radiation biodosimetry 
is another dimension of the medical management of radiation 
injuries. Radiation biodosimetry provides an estimate about the 
absorb radiation dose in the exposed individual. Presently, IAEA 
approved method (chromosal dicentric assay) of biodosimetry 
is not instant and thus unable to handle more number of 
samples in shortest period of time for triage management of 
radiation exposed persons. Therefore, other approaches need to 
be adopted to develop high-throughput radiation biodosimetry 
methods. Several approaches like, proteomics, genomics, 
metabolomics is being under investigational stage to identify 
radiation specific biomarker for triage application. 
Considering both dimensions i.e. radioprotector 
development and radiation biodosimery, present special issue on 
biological radioprotection was planned. Highly focussed articles 
from eminent researchers from India and abroad working in the 
area of radioprotector development and radiation biodosimetry 
were selected and accepted for publication in the present issue. 
Issue includes original research articles and reviews covering 
various basic and applied aspects of biological radioprotection. 
This issue includes a variety of article including plant based 
radioprotectors, bacterial compound, synthetic molecules and 
stem cell based approaches for radioprotector development. 
Similarly in radiation biodosimetry, articles dealing with 
radiation metabolomic biomarker, proteomics biomarkers, 
microfluidic devices and cytogenetic based approaches are 
included. All selected articles and review papers find their 
place in this issue was approved on the basis of independent 
peer reviews by the experts of the area from India and abroad. 
It is an honour for me to contribute as a guest editor of 
the present issue of DLSJ. I also appreciate the authors, co-
authors and expert reviewers from India and abroad for their 
excellent contribution for this present issue of DLSJ. I would 
also like to thank Editor-in-chief, editorial board and editorial 
team of DLSJ for their great support and co-operation to make 
it possible to publish the special issue of DLSJ. I also extend 
my thanks to Dr A.K. Singh, Director INMAS whole hearted 
support for the issue.
I hope the content of the issue will provide a valuable 
input to our readers and researchers alike. I request to our 
reader community to share their ideas and views to improve 
the quality of journal and its circulation beyond boundaries. 
Finally, I also request to the research community especially 
from defence life scientists across the world, kindly contribute/
submit their research work in the Journal. 
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